Overview

Version:
5.4.1101
Last updated: 2025-11-21
Ranking
#1,675,925 ▼ 8,333
Overall

Features & Capabilities

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.

User Growth & Download Statistics

App
By:
Medable, Inc.
Version:
5.4.1101 Last updated: 2025-11-21
Version code:
876705374
Creation date:
2024-07-03
Compatible devices:
Size:
100.19MB
URLs:
Website ,Privacy policy
Full description:
See detailed description
Source:
Apple Apps Store
Data ingested on:
2026-08-31
Compare stats and ranking:

Contact the developer

Chrome-Stats does not own this Apple app. Please use these information below to contact the Apple app developer.
Developed by:
Medable, Inc.
Apple Apps Store
https://apps.apple.com/us/app/j3m-mc-jzqb/id6461725046
Website:
http://medable.com

Best J3M-MC-JZQB Alternatives

Here are some Apple apps that are similar to J3M-MC-JZQB: